Prof. Dr. Daley GQ and co-workers from Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Children’s Hospital Boston (Harvard Medical School Teaching Hospital), Boston, Massachusetts, USA have reported recently in the prestigious journal Genes & Development. (April 14, 2014) that Lin28 sustains early renal progenitors and induces Wilms tumor.
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based miRNA-dependent cancer therapy: Green tea catechins inhibit the expansion of nephrogenic progenitors and wilms tumor formation by inducing their target gene. This data may suggest that Green tea catechin and its analogs may serve as one of the promising therapeutic candidates for the treatment of renal cancer.
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, Natural product-based miRNA-dependent cancer therapy: Green tea catechins inhibit the expansion of nephrogenic progenitors and wilms tumor formation by suppressing their target gene, 30/April/2014, 9.25 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at email@example.com
* Research cooperation